AcuCort is a biotechnology company. The company has developed and commercializes the drug Zeqmelit, which is an oral film based on the cortisone substance dexamethasone, for quick availability and relief in, for instance, severe and acute allergic reactions. Zeqmelit is approved in Sweden, Denmark and Norway. The goal is global commercialization in the EU, USA and in selected key markets via licensees and distributors. The company has its headquarters in Lund.